Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis

被引:31
作者
Ballot, E
Bruneel, A
Labas, V
Johanet, C
机构
[1] Hop St Antoine, APHP, Serv Immunol & Hematol Biol, F-75012 Paris, France
[2] Hop St Antoine, APHP, Serv Biochim A, F-75012 Paris, France
[3] Ecole Super Phys & Chim Ind Ville Paris, Lab Neurobiol & Diversite Cellulaire, F-75005 Paris, France
关键词
D O I
10.1373/49.4.634
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Anti-soluble liver antigen (SLA) autoantibodies are specific for autoimmune hepatitis type 1 and are the only immunologic marker found in 15-20% of hepatitis cases previously considered cryptogenic. Anti-SLA antibodies react with the 100 000g supernatant from rat liver homogenate, but the molecular targets remain controversial. Methods: We characterized anti-SLA targets by one- and two-dimensional immunoblotting analysis. The recognized proteins were identified by peptide mass fingerprint analysis after matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Results: Three proteins of 35 kDa and pI 6.0,50 kDa and pl between 6.0 and 6.5, and 58 kDa and pl between 6.5 and 7.0 were stained more intensely by anti-SLA positive-sera than by control sera. After in-gel tryptic digestion, MALDI-TOF analysis of the generated peptides enabled the clear identification of N-hydroxyarylamine sulfotransferase, isoforms of alpha-enolase, and isoforms of catalase. Conclusions: Possible antigens for anti-SLA antibodies include a sulfotransferase, alpha-enolase(s), and catalase(s). Two-dimensional electrophoresis combined with mass spectrometry offers a versatile tool to identify molecular targets of autoantibodies and thus to improve diagnostic tools and the understanding of the immune process. (C) 2003 American Association for Clinical Chemistry.
引用
收藏
页码:634 / 643
页数:10
相关论文
共 47 条
[31]   ANTIBODY TO LIVER CYTOSOL (ANTI-LC1) IN PATIENTS WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS TYPE-2 [J].
MARTINI, E ;
ABUAF, N ;
CAVALLI, F ;
DURAND, V ;
JOHANET, C ;
HOMBERG, JC .
HEPATOLOGY, 1988, 8 (06) :1662-1666
[32]  
Mills K, 2001, CLIN CHEM, V47, P2012
[33]  
NAGATA K, 1993, J BIOL CHEM, V268, P24720
[34]  
Orth T, 1998, CLIN EXP IMMUNOL, V112, P507
[35]  
Pratesi F, 2000, J RHEUMATOL, V27, P109
[36]  
Roozendaal C, 1998, CLIN EXP IMMUNOL, V112, P10
[37]   Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels [J].
Shevchenko, A ;
Wilm, M ;
Vorm, O ;
Mann, M .
ANALYTICAL CHEMISTRY, 1996, 68 (05) :850-858
[38]   Structural analysis of α-enolase -: Mapping the functional domains involved in down-regulation of the c-myc protooncogene [J].
Subramanian, A ;
Miller, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5958-5965
[39]   ELECTROPHORETIC TRANSFER OF PROTEINS FROM POLYACRYLAMIDE GELS TO NITROCELLULOSE SHEETS - PROCEDURE AND SOME APPLICATIONS [J].
TOWBIN, H ;
STAEHELIN, T ;
GORDON, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (09) :4350-4354
[40]   MOLECULAR-BASIS OF DRUG-INDUCED IMMUNOLOGICAL LIVER-INJURY [J].
VANPELT, FNAM ;
STRAUB, P ;
MANNS, MP .
SEMINARS IN LIVER DISEASE, 1995, 15 (03) :283-300